港股异动 | 中国利郎(1234.HK)续涨逾6% 品牌销量增加叠加机构看好
格隆汇10月14日丨中国利郎(1234.HK)延续近期强势,现报5.2港元,涨幅6.12%,最新总市值62.3亿港元,近四个交易日累计涨逾20%。公司12日公告称,第三季度“LILANZ”产品的零售金额(按零售价值计算)与2019年同期比较上升5%至10%。广发证券指,公司品牌利郎增长超预期。公司预期下半年零售金额同比增长不低于5%,考虑到第三季度超预期,且近期全国大范围降温,冬装销售旺季有望提前到来,公司现货补货有望增加进而带动公司业绩增长。维持“买入”评级,目标价6.25港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.